{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:43:41Z","timestamp":1795088621957,"version":"4.10.2"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66694-9","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:23:49Z","timestamp":1764563029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Computationally-designed aptamers targeting RAD51-BRCA2 interaction impair homologous recombination and induce synthetic lethality"],"prefix":"10.1038","volume":"17","author":[{"given":"Giulia","family":"Milordini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3593-6023","authenticated-orcid":false,"given":"Elsa","family":"Zacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-5206","authenticated-orcid":false,"given":"Mirco","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Armaos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3758-9045","authenticated-orcid":false,"given":"Francesco","family":"Di Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-6696","authenticated-orcid":false,"given":"Michele","family":"Oneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gilodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Rupert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Broglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Varignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-6675","authenticated-orcid":false,"given":"Stefania","family":"Girotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6370-1176","authenticated-orcid":false,"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7524-6310","authenticated-orcid":false,"given":"Gian Gaetano","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"66694_CR1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"PK HuangZhou","year":"2021","unstructured":"HuangZhou, P. K. & Zhou, P.-K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct. Target Ther. 6, 254 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"66694_CR2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/cancers12041050","volume":"12","author":"MI AlhmoudMalki","year":"2020","unstructured":"AlhmoudMalki, M. I., Woolley, J. F., Al Moustafa, A.-E. & Malki, M. I. DNA damage\/repair management in cancers. Cancers 12, 1050 (2020).","journal-title":"Cancers"},{"key":"66694_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D HanahanWeinberg","year":"2011","unstructured":"HanahanWeinberg, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"66694_CR4","unstructured":"YaoDai, Y. & Dai, W. Genomic Instability and Cancer. J Carcinog Mutagen 5 (2014)."},{"key":"66694_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biotech13010003","volume":"13","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Exploring DNA damage and repair mechanisms: a review with computational insights. BioTech. (Basel) 13, 3 (2024).","journal-title":"BioTech. (Basel)"},{"key":"66694_CR6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","volume":"20","author":"R ScullyWillis","year":"2019","unstructured":"ScullyWillis, R., Panday, A., Elango, R. & Willis, N. A. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat. Rev. Mol. Cell Biol. 20, 698\u2013714 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"66694_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10577-019-09617-x","volume":"27","author":"N ThadathilKhan","year":"2019","unstructured":"ThadathilKhan, N., Hori, R., Xiao, J. & Khan, M. M. DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases. Chromosome Res. 27, 345\u2013364 (2019).","journal-title":"Chromosome Res."},{"key":"66694_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","volume":"77","author":"J San FilippoKlein","year":"2008","unstructured":"San FilippoKlein, J., Sung, P. & Klein, H. Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 77, 229\u2013257 (2008).","journal-title":"Annu. Rev. Biochem."},{"key":"66694_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.06.012","volume":"113","author":"A CarverZhang","year":"2021","unstructured":"CarverZhang, A. & Zhang, X. Rad51 filament dynamics and its antagonistic modulators. Semin. Cell Dev. Biol. 113, 3\u201313 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"66694_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-genet-021920-092410","volume":"54","author":"B BonillaBernstein","year":"2020","unstructured":"BonillaBernstein, B., Hengel, S. R., Grundy, M. K. & Bernstein, K. A. RAD51 gene family structure and function. Annu. Rev. Genet. 54, 25\u201346 (2020).","journal-title":"Annu. Rev. Genet."},{"key":"66694_CR11","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.1073\/pnas.0902723106","volume":"106","author":"A ReymerNord\u00e9n","year":"2009","unstructured":"ReymerNord\u00e9n, A., Frykholm, K., Morimatsu, K., Takahashi, M. & Nord\u00e9n, B. Structure of human Rad51 protein filament from molecular modeling and site-specific linear dichroism spectroscopy. Proc. Natl. Acad. Sci. USA 106, 13248\u201313253 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66694_CR12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature09399","volume":"467","author":"RB Jensen","year":"2010","unstructured":"Jensen, R. B., Carreira, A. & Kowalczykowski, S. C. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467, 678\u2013683 (2010).","journal-title":"Nature"},{"key":"66694_CR13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/nsmb.1904","volume":"17","author":"J LiuHeyer","year":"2010","unstructured":"LiuHeyer, J., Doty, T., Gibson, B. & Heyer, W.-D. Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA. Nat. Struct. Mol. Biol. 17, 1260\u20131262 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66694_CR14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nsmb.1905","volume":"17","author":"T Thorslund","year":"2010","unstructured":"Thorslund, T. et al. The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA. Nat. Struct. Mol. Biol. 17, 1263\u20131265 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66694_CR15","doi-asserted-by":"crossref","first-page":"a016410","DOI":"10.1101\/cshperspect.a016410","volume":"7","author":"SC Kowalczykowski","year":"2015","unstructured":"Kowalczykowski, S. C. An overview of the molecular mechanisms of recombinational DNA repair. Cold Spring Harb. Perspect. Biol. 7, a016410 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"66694_CR16","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1093\/nar\/gkx084","volume":"45","author":"H S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez, H. et al. Architectural plasticity of human BRCA2-RAD51 complexes in DNA break repair. Nucleic Acids Res. 45, 4507\u20134518 (2017).","journal-title":"Nucleic Acids Res."},{"key":"66694_CR17","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1158\/1535-7163.MCT-17-1156","volume":"17","author":"A TrennerSartori","year":"2018","unstructured":"TrennerSartori, A., Godau, J. & Sartori, A. A. A short BRCA2-derived cell-penetrating peptide targets RAD51 function and confers hypersensitivity toward PARP inhibition. Mol. Cancer Ther. 17, 1392\u20131404 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"66694_CR18","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acsmedchemlett.2c00063","volume":"13","author":"G Bagnolini","year":"2022","unstructured":"Bagnolini, G. et al. Identification of RAD51-BRCA2 inhibitors using N-acylhydrazone-based dynamic combinatorial chemistry. ACS Med. Chem. Lett. 13, 1262\u20131269 (2022).","journal-title":"ACS Med. Chem. Lett."},{"key":"66694_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature01230","volume":"420","author":"L Pellegrini","year":"2002","unstructured":"Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420, 287\u2013293 (2002).","journal-title":"Nature"},{"key":"66694_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ LordAshworth","year":"2016","unstructured":"LordAshworth, C. J. & Ashworth, A. BRCAness revisited. Nat. Rev. Cancer 16, 110\u2013120 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"66694_CR21","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.jmedchem.9b01526","volume":"63","author":"G Bagnolini","year":"2020","unstructured":"Bagnolini, G. et al. Synthetic lethality in pancreatic cancer: Discovery of a new RAD51-BRCA2 small molecule disruptor that inhibits homologous recombination and synergizes with olaparib. J. Med. Chem. 63, 2588\u20132619 (2020).","journal-title":"J. Med. Chem."},{"key":"66694_CR22","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41588-023-01557-x","volume":"55","author":"CJ Ryan","year":"2023","unstructured":"Ryan, C. J., Devakumar, L. P. S., Pettitt, S. J. & Lord, C. J. Complex synthetic lethality in cancer. Nat. Genet. 55, 2039\u20132048 (2023).","journal-title":"Nat. Genet."},{"key":"66694_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2010.11.024","volume":"585","author":"SMB Nijman","year":"2011","unstructured":"Nijman, S. M. B. Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett. 585, 1\u20136 (2011).","journal-title":"FEBS Lett."},{"key":"66694_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40265-015-0345-6","volume":"75","author":"ED Deeks","year":"2015","unstructured":"Deeks, E. D. Olaparib: first global approval. Drugs 75, 231\u2013240 (2015).","journal-title":"Drugs"},{"key":"66694_CR25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"66694_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.gendis.2023.02.014","volume":"11","author":"X Fu","year":"2024","unstructured":"Fu, X. et al. Mechanism of PARP inhibitor resistance and potential overcoming strategies. Genes Dis. 11, 306\u2013320 (2024).","journal-title":"Genes Dis."},{"key":"66694_CR27","doi-asserted-by":"crossref","unstructured":"RoseBolderson, M., Burgess, J. T., O\u2019Byrne, K., Richard, D. J. & Bolderson, E. PARP inhibitors: Clinical relevance, mechanisms of action and tumor resistance. Front. Cell Dev. Biol. 8 (2020).","DOI":"10.3389\/fcell.2020.564601"},{"key":"66694_CR28","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/acschembio.7b00707","volume":"12","author":"F Falchi","year":"2017","unstructured":"Falchi, F. et al. Synthetic lethality triggered by combining Olaparib with BRCA2-Rad51 disruptors. ACS Chem. Biol. 12, 2491\u20132497 (2017).","journal-title":"ACS Chem. Biol."},{"key":"66694_CR29","volume":"23","author":"O ElyashivLedermann","year":"2021","unstructured":"ElyashivLedermann, O., Wong, Y. N. S. & Ledermann, J. A. Frontline Maintenance Treatment for Ovarian Cancer. Curr. Oncol. Rep. 23, 97 (2021).","journal-title":"Curr. Oncol. Rep."},{"key":"66694_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan, T. et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N. Engl. J. Med. 381, 317\u2013327 (2019).","journal-title":"N. Engl. J. Med."},{"key":"66694_CR31","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.3390\/ijms23158338","volume":"23","author":"F Schipani","year":"2022","unstructured":"Schipani, F. et al. The mechanistic understanding of RAD51 defibrillation: a critical step in BRCA2-mediated DNA repair by homologous recombination. Int. J. Mol. Sci. 23, 8338 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"66694_CR32","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1021\/acs.jmedchem.4c00113","volume":"67","author":"V Previtali","year":"2024","unstructured":"Previtali, V. et al. New Horizons of synthetic lethality in cancer: current development and future perspectives. J. Med. Chem. 67, 11488\u201311521 (2024).","journal-title":"J. Med. Chem."},{"key":"66694_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.chembiol.2021.02.006","volume":"28","author":"DE Scott","year":"2021","unstructured":"Scott, D. E. et al. A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death. Cell Chem. Biol. 28, 835\u2013847.e5 (2021).","journal-title":"Cell Chem. Biol."},{"key":"66694_CR34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"AD EllingtonSzostak","year":"1990","unstructured":"EllingtonSzostak, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818\u2013822 (1990).","journal-title":"Nature"},{"key":"66694_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C TuerkGold","year":"1990","unstructured":"TuerkGold, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505\u2013510 (1990).","journal-title":"Science"},{"key":"66694_CR36","volume":"10","author":"F Gao","year":"2022","unstructured":"Gao, F. et al. Recent advances in aptamer-based targeted drug delivery systems for cancer therapy. Front Bioeng. Biotechnol. 10, 972933 (2022).","journal-title":"Front Bioeng. Biotechnol."},{"key":"66694_CR37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","volume":"9","author":"AD KeefeEllington","year":"2010","unstructured":"KeefeEllington, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537\u2013550 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"66694_CR38","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.3390\/ijms25136833","volume":"25","author":"M DomsicovaBreier","year":"2024","unstructured":"DomsicovaBreier, M., Korcekova, J., Poturnayova, A. & Breier, A. New insights into aptamers: an alternative to antibodies in the detection of molecular biomarkers. Int. J. Mol. Sci. 25, 6833 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"66694_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J ZhouRossi","year":"2017","unstructured":"ZhouRossi, J. & Rossi, J. Aptamers as targeted therapeutics: current potential and challenges. Nat. Rev. Drug Discov. 16, 181\u2013202 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"66694_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30944-x","volume":"13","author":"E Zacco","year":"2022","unstructured":"Zacco, E. et al. Probing TDP-43 condensation using an in silico designed aptamer. Nat. Commun. 13, 3306 (2022).","journal-title":"Nat. Commun."},{"key":"66694_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2019.09.011","volume":"178","author":"A DastiTartaglia","year":"2020","unstructured":"DastiTartaglia, A., Cid-Samper, F., Bechara, E. & Tartaglia, G. G. RNA-centric approaches to study RNA-protein interactions in vitro and in silico. Methods 178, 11\u201318 (2020).","journal-title":"Methods"},{"key":"66694_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00401-024-02705-1","volume":"147","author":"H Spence","year":"2024","unstructured":"Spence, H. et al. RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. Acta Neuropathol. 147, 50 (2024).","journal-title":"Acta Neuropathol."},{"key":"66694_CR43","doi-asserted-by":"crossref","first-page":"W72","DOI":"10.1093\/nar\/gkab393","volume":"49","author":"A ArmaosTartaglia","year":"2021","unstructured":"ArmaosTartaglia, A., Colantoni, A., Proietti, G., Rupert, J. & Tartaglia, G. G. catRAPID omics v2.0: going deeper and wider in the prediction of protein-RNA interactions. Nucleic Acids Res. 49, W72\u2013W79 (2021).","journal-title":"Nucleic Acids Res."},{"key":"66694_CR44","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.csbj.2025.06.027","volume":"27","author":"J Luige","year":"2025","unstructured":"Luige, J. et al. Design and characterization of G-quadruplex RNA aptamers reveal RNA-binding by KDM5 lysine demethylases. Comput. Struct. Biotechnol. J. 27, 2719\u20132729 (2025).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"66694_CR45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nmeth.1611","volume":"8","author":"M BellucciTartaglia","year":"2011","unstructured":"BellucciTartaglia, M., Agostini, F., Masin, M. & Tartaglia, G. G. Predicting protein associations with long noncoding RNAs. Nat. Methods 8, 444\u2013445 (2011).","journal-title":"Nat. Methods"},{"key":"66694_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nmeth.4100","volume":"14","author":"D Cirillo","year":"2016","unstructured":"Cirillo, D. et al. Quantitative predictions of protein interactions with long noncoding RNAs. Nat. Methods 14, 5\u20136 (2016).","journal-title":"Nat. Methods"},{"key":"66694_CR47","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.biochi.2010.08.006","volume":"92","author":"SF Martinez","year":"2010","unstructured":"Martinez, S. F. et al. Targeting human Rad51 by specific DNA aptamers induces inhibition of homologous recombination. Biochimie 92, 1832\u20131838 (2010).","journal-title":"Biochimie"},{"key":"66694_CR48","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/bioinformatics\/btt495","volume":"29","author":"F Agostini","year":"2013","unstructured":"Agostini, F. et al. catRAPID omics: a web server for large-scale prediction of protein-RNA interactions. Bioinformatics 29, 2928\u20132930 (2013).","journal-title":"Bioinformatics"},{"key":"66694_CR49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41594-019-0223-0","volume":"26","author":"A Cerase","year":"2019","unstructured":"Cerase, A. et al. Phase separation drives X-chromosome inactivation: a hypothesis. Nat. Struct. Mol. Biol. 26, 331\u2013334 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66694_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10923-5","volume":"10","author":"N Sanchez de Groot","year":"2019","unstructured":"Sanchez de Groot, N. et al. RNA structure drives interaction with proteins. Nat. Commun. 10, 3246 (2019).","journal-title":"Nat. Commun."},{"key":"66694_CR51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"66694_CR52","doi-asserted-by":"crossref","unstructured":"Brouwer, I. et al. Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA. EMBO J. 37 (2018).","DOI":"10.15252\/embj.201798162"},{"key":"66694_CR53","doi-asserted-by":"crossref","first-page":"gkw783","DOI":"10.1093\/nar\/gkw783","volume":"44","author":"JM Short","year":"2016","unstructured":"Short, J. M. et al. High-resolution structure of the presynaptic RAD51 filament on single-stranded DNA by electron cryo-microscopy. Nucleic Acids Res. 44, gkw783 (2016).","journal-title":"Nucleic Acids Res."},{"key":"66694_CR54","volume":"14","author":"R ApplebyPellegrini","year":"2023","unstructured":"ApplebyPellegrini, R., Joudeh, L., Cobbett, K. & Pellegrini, L. Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2. Nat. Commun. 14, 7003 (2023).","journal-title":"Nat. Commun."},{"key":"66694_CR55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mrd.22501","volume":"82","author":"C De Los Santos","year":"2015","unstructured":"De Los Santos, C., Chang, C. W., Mycek, M. A.-W. & Cardullo, R. A. Detection and analysis of cellular dynamics on a molecular scale using fluorescence microscopy. Mol. Reprod. Dev. 82, 587\u2013604 (2015).","journal-title":"Mol. Reprod. Dev."},{"key":"66694_CR56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2818.2012.03618.x","volume":"247","author":"W Becker","year":"2012","unstructured":"Becker, W. Fluorescence lifetime imaging-techniques and applications. J. Microsc. 247, 119\u2013136 (2012).","journal-title":"J. Microsc."},{"key":"66694_CR57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41420-025-02382-3","volume":"11","author":"M Masi","year":"2025","unstructured":"Masi, M. et al. Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity. Cell Death Discov. 11, 106 (2025).","journal-title":"Cell Death Discov."},{"key":"66694_CR58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oncolo\/oyab053","volume":"27","author":"MD Stewart","year":"2022","unstructured":"Stewart, M. D. et al. Homologous recombination deficiency: Concepts, definitions, and assays. Oncologist 27, 167\u2013174 (2022).","journal-title":"Oncologist"},{"key":"66694_CR59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2443.2006.00958.x","volume":"11","author":"E MladenovTsaneva","year":"2006","unstructured":"MladenovTsaneva, E., Anachkova, B. & Tsaneva, I. Sub-nuclear localization of Rad51 in response to DNA damage. Genes Cells 11, 513\u2013524 (2006).","journal-title":"Genes Cells"},{"key":"66694_CR60","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2018.04.016","volume":"70","author":"EK Brinkman","year":"2018","unstructured":"Brinkman, E. K. et al. Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks. Mol. Cell 70, 801\u2013813.e6 (2018).","journal-title":"Mol. Cell"},{"key":"66694_CR61","volume":"11","author":"N Yamashita","year":"2021","unstructured":"Yamashita, N. et al. Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice. Sci. Rep. 11, 20920 (2021).","journal-title":"Sci. Rep."},{"key":"66694_CR62","doi-asserted-by":"crossref","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","volume":"73","author":"CRR Rocha","year":"2018","unstructured":"Rocha, C. R. R., Silva, M. M., Quinet, A., Cabral-Neto, J. B. & Menck, C. F. M. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics 73, e478s (2018).","journal-title":"Clinics"},{"key":"66694_CR63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41592-018-0291-9","volume":"16","author":"M Castello","year":"2019","unstructured":"Castello, M. et al. A robust and versatile platform for image scanning microscopy enabling super-resolution FLIM. Nat. Methods 16, 175\u2013178 (2019).","journal-title":"Nat. Methods"},{"key":"66694_CR64","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1038\/s41388-021-01932-0","volume":"40","author":"H Sun","year":"2021","unstructured":"Sun, H. et al. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. Oncogene 40, 5342\u20135355 (2021).","journal-title":"Oncogene"},{"key":"66694_CR65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2019.01.008","volume":"165","author":"M Roberti","year":"2019","unstructured":"Roberti, M. et al. Rad51\/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells. Eur. J. Med. Chem. 165, 80\u201392 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"66694_CR66","doi-asserted-by":"crossref","first-page":"116114","DOI":"10.1016\/j.ejmech.2023.116114","volume":"265","author":"SH Myers","year":"2024","unstructured":"Myers, S. H. et al. An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer. Eur. J. Med. Chem. 265, 116114 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"66694_CR67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/07357908609039823","volume":"4","author":"MH Tan","year":"1986","unstructured":"Tan, M. H. et al. Characterization of a new primary human pancreatic tumor line. Cancer Invest 4, 15\u201323 (1986).","journal-title":"Cancer Invest"},{"key":"66694_CR68","volume":"1","author":"GS Cowley","year":"2014","unstructured":"Cowley, G. S. et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. Data 1, 140035 (2014).","journal-title":"Sci. Data"},{"key":"66694_CR69","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10555-021-09983-1","volume":"40","author":"F CrowleyO\u2019Reilly","year":"2021","unstructured":"CrowleyO\u2019Reilly, F., Park, W. & O\u2019Reilly, E. M. Targeting DNA damage repair pathways in pancreas cancer. Cancer Metastasis Rev. 40, 891\u2013908 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"66694_CR70","doi-asserted-by":"crossref","first-page":"103177","DOI":"10.1016\/j.dnarep.2021.103177","volume":"106","author":"U RayRaghavan","year":"2021","unstructured":"RayRaghavan, U. & Raghavan, S. C. Understanding the DNA double-strand break repair and its therapeutic implications. DNA Repair (Amst.) 106, 103177 (2021).","journal-title":"DNA Repair (Amst.)"},{"key":"66694_CR71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/85798","volume":"27","author":"KK KhannaJackson","year":"2001","unstructured":"KhannaJackson, K. K. & Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247\u2013254 (2001).","journal-title":"Nat. Genet."},{"key":"66694_CR72","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/carcin\/bgaa114","volume":"41","author":"J Patel","year":"2020","unstructured":"Patel, J. et al. DNA damage and mitochondria in cancer and aging. Carcinogenesis 41, 1625\u20131634 (2020).","journal-title":"Carcinogenesis"},{"key":"66694_CR73","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","volume":"592","author":"B SchumacherHoeijmakers","year":"2021","unstructured":"SchumacherHoeijmakers, B., Pothof, J., Vijg, J. & Hoeijmakers, J. H. J. The central role of DNA damage in the ageing process. Nature 592, 695\u2013703 (2021).","journal-title":"Nature"},{"key":"66694_CR74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","volume":"920","author":"A Sharma","year":"2012","unstructured":"Sharma, A., Singh, K. & Almasan, A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol. Biol. 920, 613\u2013626 (2012).","journal-title":"Methods Mol. Biol."},{"key":"66694_CR75","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11523-019-00680-2","volume":"14","author":"E SachdevMita","year":"2019","unstructured":"SachdevMita, E., Tabatabai, R., Roy, V., Rimel, B. J. & Mita, M. M. PARP inhibition in cancer: an update on clinical development. Target. Oncol. 14, 657\u2013679 (2019).","journal-title":"Target. Oncol."},{"key":"66694_CR76","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor, M. J. Targeting the DNA damage response in cancer. Mol. Cell 60, 547\u2013560 (2015).","journal-title":"Mol. Cell"},{"key":"66694_CR77","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-95","volume":"13","author":"P Longati","year":"2013","unstructured":"Longati, P. et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13, 95 (2013).","journal-title":"BMC Cancer"},{"key":"66694_CR78","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/s41388-018-0257-5","volume":"37","author":"S Kota","year":"2018","unstructured":"Kota, S. et al. A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype. Oncogene 37, 4372\u20134384 (2018).","journal-title":"Oncogene"},{"key":"66694_CR79","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41416-021-01469-9","volume":"125","author":"E Lai","year":"2021","unstructured":"Lai, E. et al. BRCA-mutant pancreatic ductal adenocarcinoma. Br. J. Cancer 125, 1321\u20131332 (2021).","journal-title":"Br. J. Cancer"},{"key":"66694_CR80","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.dnarep.2007.12.008","volume":"7","author":"HL Klein","year":"2008","unstructured":"Klein, H. L. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair 7, 686\u2013693 (2008).","journal-title":"DNA Repair"},{"key":"66694_CR81","volume":"19","author":"X ZhangRen","year":"2019","unstructured":"ZhangRen, X., Ma, N., Yao, W., Li, S. & Ren, Z. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer. Cancer Cell Int. 19, 356 (2019).","journal-title":"Cancer Cell Int."},{"key":"66694_CR82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0300-483X(03)00291-9","volume":"193","author":"W HenningSt\u00fcrzbecher","year":"2003","unstructured":"HenningSt\u00fcrzbecher, W. & St\u00fcrzbecher, H. W. Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology 193, 91\u2013109 (2003).","journal-title":"Toxicology"},{"key":"66694_CR83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.it.2016.12.004","volume":"38","author":"A ZeviniHiscott","year":"2017","unstructured":"ZeviniHiscott, A., Olagnier, D. & Hiscott, J. Crosstalk between cytoplasmic RIG-I and STING sensing pathways. Trends Immunol. 38, 194\u2013205 (2017).","journal-title":"Trends Immunol."},{"key":"66694_CR84","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/acsptsci.2c00156","volume":"5","author":"AS ShraimHunaiti","year":"2022","unstructured":"ShraimHunaiti, A. S., Abdel Majeed, B. A., Al-Binni, M. A. & Hunaiti, A. Therapeutic potential of aptamer-protein interactions. ACS Pharmacol. Transl. Sci. 5, 1211\u20131227 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"66694_CR85","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/1873-3468.12139","volume":"590","author":"DE ScottHyv\u00f6nen","year":"2016","unstructured":"ScottHyv\u00f6nen, D. E., Marsh, M., Blundell, T. L., Abell, C. & Hyv\u00f6nen, M. Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction. FEBS Lett. 590, 1094\u20131102 (2016).","journal-title":"FEBS Lett."},{"key":"66694_CR86","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1568-7864(03)00097-1","volume":"2","author":"T LoBlundell","year":"2003","unstructured":"LoBlundell, T., Pellegrini, L., Venkitaraman, A. R. & Blundell, T. L. Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer. DNA Repair 2, 1015\u20131028 (2003).","journal-title":"DNA Repair"},{"key":"66694_CR87","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1093\/nar\/gkae452","volume":"52","author":"S Miron","year":"2024","unstructured":"Miron, S. et al. DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces. Nucleic Acids Res. 52, 7337\u20137353 (2024).","journal-title":"Nucleic Acids Res."},{"key":"66694_CR88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/nar\/gkp873","volume":"38","author":"E RajendraVenkitaraman","year":"2010","unstructured":"RajendraVenkitaraman, E. & Venkitaraman, A. R. Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase. Nucleic Acids Res. 38, 82\u201396 (2010).","journal-title":"Nucleic Acids Res."},{"key":"66694_CR89","doi-asserted-by":"crossref","first-page":"33\u20138, 27\u20138","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u20138, 27\u20138 (1996).","journal-title":"J. Mol. Graph."},{"key":"66694_CR90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte Cordeli\u00e8res","year":"2006","unstructured":"Bolte Cordeli\u00e8res, S. & Cordeli\u00e8res, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213\u2013232 (2006).","journal-title":"J. Microsc."},{"key":"66694_CR91","doi-asserted-by":"crossref","unstructured":"Buoso, E. et al. Disruption of epithelial barrier integrity via altered GILZ\/c-Rel\/RACK1 signaling in inflammatory bowel disease. J. Crohns. Colitis 19 (2025).","DOI":"10.1093\/ecco-jcc\/jjae191"},{"key":"66694_CR92","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3390\/ijms24076639","volume":"24","author":"M Masi","year":"2023","unstructured":"Masi, M. et al. The labyrinthine landscape of APP processing: State of the art and possible novel soluble APP-related molecular players in Traumatic Brain Injury and neurodegeneration. Int. J. Mol. Sci. 24, 6639 (2023).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66694-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66694-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66694-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:03:12Z","timestamp":1767679392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66694-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66694"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66694-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent on the aptamers has been filed (PCT\/IB2025\/059812, Italian priority application N. IT102024000004522) on which G.G.T., A.C., E.Z., G.M., A.A., M.G., J.R., S.G., M.O., M.S., and M.M. are named as inventors. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}